New painkiller could rival morphine after heart surgery
NCT ID NCT07451522
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new pain medicine called tafalgin against morphine in 100 adults recovering from coronary artery bypass grafting (CABG). Participants receive either a single shot of morphine or tafalgin when their pain level is high. The goal is to see if tafalgin controls pain just as well, while causing fewer side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANALGESIA ASSESSMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Primorsky Regional General Hospital #1
RECRUITINGVladivostok, Outside US, 690091, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could skipping the breathing tube speed heart surgery recovery?
- Timing is everything: could physiotherapy minutes after extubation prevent lung complications?
- A 15-Minute heart MRI could speed up diagnosis of coronary artery disease
- Pre-surgery exercise program may help high-risk heart patients leave the hospital sooner
- New study tests safer pain control for High-Risk amputation patients
- Heart surgery showdown: which solution saves more heart muscle?